PT - JOURNAL ARTICLE AU - Ivan Brdar AU - Ivan Jerković AU - Željana Bašić AU - Nenad Kunac AU - Deny Anđelinović AU - Joško Bezić AU - Ivana Kružić AU - Arijana Vuko AU - Šimun Anđelinović TI - ABO and Rh blood groups, demographics, and comorbidities in COVID-19 related deaths: a retrospective study in Split-Dalmatia County, Croatia AID - 10.1101/2021.07.16.21260630 DP - 2021 Jan 01 TA - medRxiv PG - 2021.07.16.21260630 4099 - http://medrxiv.org/content/early/2021/07/19/2021.07.16.21260630.short 4100 - http://medrxiv.org/content/early/2021/07/19/2021.07.16.21260630.full AB - Aim To examine ABO and Rh blood group distribution in COVID-19 related deaths considering demographics and pathological conditions.Materials and Methods We conducted a retrospective study at the University Hospital Centre Split, Croatia, that included 245 COVID-positive individuals that died from April 8, 2020, to January 25, 2021. From the hospital database, we extracted data on their blood groups, demographics, and pre-existing comorbidities. To compare findings with the general population, we used information from collected blood group donations (n = 101357) and statistical reports of non-COVID deaths from 2019 (n = 4968).Results The proportion of males was significantly higher in analyzed subjects than in non- COVID deaths from 2019 (63.7% vs. 48.9%, P < 0.001), while the proportion of older individuals did not differ (P = 0.8). The most common pre-existing diseases were hypertension (59.6%), diabetes (37.1%), heart failure (28.8%), digestive disorder (26.5%), and solid tumor (21.6%). The ABO distribution in the deceased and donors’ group showed statistically significant differences, with the higher prevalence of A/AB group and lower prevalence of 0, but with individual differences significant only for AB and non-AB groups. There was a significantly reduced proportion of females within the deceased with group 0 (P = 0.014) and a higher proportion of AB individuals with coronary heart disease (P = 0.024), while other differences were not significant.Conclusion The study confirmed a higher risk of death in male individuals. The lower proportion of type 0 in deceased individuals was more pronounced in females, implying that group 0 is not necessarily an independent protective factor. Among analyzed comorbidities, coronary heart disease was identified as a potential risk factor for AB individuals.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo funding recieved.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the ethical committee of University Hospital Centre Split on June 15, 2020 (500-03/20-01/09; 2181-147-01/06/M.S.-20-12).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data that support the findings of this study are available on request from the corresponding author.